Pavlová Tereza, Novák Jan, Bienertová-Vašků Julie
Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A18, Brno 62500, Czech Republic.
Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Kamenice 5, Building A18, Brno 62500, Czech Republic; Regional Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Žlutý kopec 7, Brno 65653, Czech Republic.
J Reprod Immunol. 2015 Nov;112:102-10. doi: 10.1016/j.jri.2015.09.004. Epub 2015 Sep 21.
Visfatin (PBEF/Nampt) is an adipocytokine that exerts pleiotropic effects within the human body, particularly affecting its metabolism and immunity. Visfatin was originally identified as being secreted by peripheral blood lymphocytes acting as a pre-B-cell colony-enhancing factor (PBEF). However, it was subsequently reported to be expressed in almost every tissue of the human body, with visceral fat deposits being the main source of visfatin. In addition to its secreted form, visfatin may also be found intracellularly where it functions as a nicotinamide phosphoribosyltransferase (Nampt). Visfatin maternal plasma concentrations increase during pregnancy, suggesting its important role in this complicated process. Alterations in visfatin level also take place in patients during pregnancy complications. This review focuses on the ones that most commonly occur in connection with visfatin: preterm labor, pre-eclampsia and gestational diabetes mellitus. The review aims to provide a better understanding of the role of visfatin during pregnancy and the causes of its alteration in maternal plasma, highlighting the potential use of visfatin as a diagnostic marker of pregnancy complications in the future.
内脂素(PBEF/Nampt)是一种脂肪细胞因子,在人体内发挥多效性作用,尤其影响人体代谢和免疫。内脂素最初被鉴定为由外周血淋巴细胞分泌,作为前B细胞集落增强因子(PBEF)。然而,随后有报道称其在人体几乎每个组织中都有表达,内脏脂肪沉积是内脂素的主要来源。除了其分泌形式外,内脂素也可能存在于细胞内,在细胞内它作为烟酰胺磷酸核糖转移酶(Nampt)发挥作用。孕期母体内脂素血浆浓度会升高,表明其在这一复杂过程中发挥重要作用。孕期并发症患者体内内脂素水平也会发生变化。本综述重点关注与内脂素最常相关的并发症:早产、子痫前期和妊娠期糖尿病。本综述旨在更好地理解内脂素在孕期的作用及其母血中水平变化的原因,强调内脂素未来作为孕期并发症诊断标志物的潜在用途。